17-beta-hydroxysteroid dehydrogenase deficiency genotyping: Difference between revisions
No edit summary |
Jose Loyola (talk | contribs) No edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{17-beta-hydroxysteroid dehydrogenase deficiency}} | {{17-beta-hydroxysteroid dehydrogenase deficiency}} | ||
17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characterstics. There has been no [[phenotype]] to [[genotype correlation]].<ref name="pmid20689261">{{cite journal| author=George MM, New MI, Ten S, Sultan C, Bhangoo A| title=The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. | journal=Horm Res Paediatr | year= 2010 | volume= 74 | issue= 4 | pages= 229-40 | pmid=20689261 | doi=10.1159/000318004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20689261 }} </ref> | {{CMG}}; {{AE}} {{Abdulkerim}} | ||
==Overview== | |||
17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characteristics. There has been no [[phenotype]] to [[genotype correlation]]. | |||
==Genotyping== | |||
*17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characterstics. There has been no [[phenotype]] to [[genotype correlation]].<ref name="pmid20689261">{{cite journal| author=George MM, New MI, Ten S, Sultan C, Bhangoo A| title=The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. | journal=Horm Res Paediatr | year= 2010 | volume= 74 | issue= 4 | pages= 229-40 | pmid=20689261 | doi=10.1159/000318004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20689261 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 09:44, 13 October 2022
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency genotyping On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency genotyping |
|
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping |
|
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping |
|
17-beta-hydroxysteroid dehydrogenase deficiency genotyping in the news |
|
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
|
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency genotyping |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Overview
17 beta hydroxysteroid dehydrogenase deficiency is a condition with genotypically male and phenotypically female characteristics. There has been no phenotype to genotype correlation.
Genotyping
- 17 beta hydroxysteroid dehydrogenase deficiency is a condition with genotypically male and phenotypically female characterstics. There has been no phenotype to genotype correlation.[1]
References
- ↑ George MM, New MI, Ten S, Sultan C, Bhangoo A (2010). "The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency". Horm Res Paediatr. 74 (4): 229–40. doi:10.1159/000318004. PMID 20689261.